NOVOEIGHT

This brand name is authorized in Austria, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug NOVOEIGHT contains one active pharmaceutical ingredient (API):

1	Coagulation factor VIII UNII 969NZA3X9T - TUROCTOCOG ALFA
	Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies.
	Read more about Coagulation factor VIII

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD	Blood coagulation factors	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics
Discover more medicines within B02BD
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	110-MBE-0817, 111-MBE-0817, 116-MBE-0917
EE	Ravimiamet	1633485, 1633496, 1633508, 1633519, 1633520, 1633531
ES	Centro de información online de medicamentos de la AEMPS	113888001, 113888002, 113888003, 113888004, 113888005, 113888006
FI	Lääkealan turvallisuus- ja kehittämiskeskus	379853, 420551, 489534, 502125
FR	Base de données publique des médicaments	62333524, 64266526, 65044350, 66990599, 67582344, 68274043
GB	Medicines & Healthcare Products Regulatory Agency	246093, 334179, 334183, 334190, 334194, 334198
IL	מִשְׂרַד הַבְּרִיאוּת	8014, 8015, 8029
IT	Agenzia del Farmaco	043153016, 043153028, 043153030, 043153042, 043153055, 043153067
JP	医薬品医療機器総合機構	6343440D1023, 6343440D2020, 6343440D3026, 6343440D4022, 6343440D5029, 6343440D6025
LT	Valstybinė vaistų kontrolės tarnyba	1072077, 1072078, 1072079, 1072080, 1072081, 1072082
NL	Z-Index G-Standaard, PRK	112399, 112402, 112410, 112429, 112437, 112445
NZ	Medicines and Medical Devices Safety Authority	17261, 17263, 17264, 17265, 17266, 17267
PL	Rejestru Produktów Leczniczych	100312050, 100312067, 100312080, 100312096, 100312104, 100312127
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65188001, W65189001, W65190001, W65191001, W65192001, W65193001
TN	Direction de la Pharmacie et du Médicament	5993121H, 5993122H, 5993123H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699676790654, 8699676790661, 8699676790678, 8699676790685, 8699676790692, 8699676790708